1. Home
  2. RDNT vs RLAY Comparison

RDNT vs RLAY Comparison

Compare RDNT & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RadNet Inc.

RDNT

RadNet Inc.

HOLD

Current Price

$72.39

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$19.77

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDNT
RLAY
Founded
1985
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.1B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
RDNT
RLAY
Price
$72.39
$19.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
10
Target Price
$82.80
$19.50
AVG Volume (30 Days)
645.3K
2.2M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.78
EPS
N/A
N/A
Revenue
$1,616,630,000.00
$15,355,000.00
Revenue This Year
$22.78
N/A
Revenue Next Year
$10.70
$324.03
P/E Ratio
N/A
N/A
Revenue Growth
13.05
53.44
52 Week Low
$50.82
$3.15
52 Week High
$85.84
$20.79

Technical Indicators

Market Signals
Indicator
RDNT
RLAY
Relative Strength Index (RSI) 62.91 59.15
Support Level $64.71 $18.02
Resistance Level $71.79 $20.59
Average True Range (ATR) 2.69 0.96
MACD 0.50 -0.06
Stochastic Oscillator 86.53 76.12

Price Performance

Historical Comparison
RDNT
RLAY

About RDNT RadNet Inc.

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: